The Position Our client has a fantastic opportunity for a Haematologist on a full time basis. The Hospital This is 370 bed public hospital, Aged Care & Rehabilitation Service, Community Health Service and Mental Health Service all locat...
For further information about this job, please contact Nickola Hoffmann on 1300 900 100. Locum Medical Officer - Medical... duties. About Skilled Medical Skilled Medical is a leading international medical recruitment firm that delivers qualified...
Medical Receptionist - thorough Genie experience essential $35 - $45 per hour Are you an experienced Medical... Requirements - please only apply if you meet the following: You have at least six months of medical and Genie experience. You can...
The Position Our client is seeking a full-time Emergency Medicine Consultant to join their team. There is also the possibility of various fixed-term appointments lasting up to 5 years. The Location This charming seaside city is widely r...
Indian benchmark indices continue bullish streak, fueled by potential rate cut by US Federal Reserve, FPI inflows, and rally in banking and IT stocks. Nifty 50 ends week with 1.30% gain, hitting new all-time high. Mid- and small-cap stocks also show strong performance. Continue Reading »
According to data collected from the Bombay Stock Exchange (BSE) website, the Emcure Pharmaceuticals IPO issue was oversubscribed 67.86 times. Qualified institutional buyers (QIB), non-institutional investors (NII), and retail investors showed strong bids on the third day. Continue Reading »
Anand Rathi recommends 2 'emerging picks' for July 2024, focusing on CONCOR and ideaForge Technology with a time horizon of 30-90 days. Continue Reading »
Stock Market Today: Sun Pharma share price has risen almost 25% year to date. The news flow recently has remained around regulatory actions by the USFDA for Dadra nd Halol plant Should you Buy , Sell or Hold the stock? Continue Reading »
Bansal Wire IPO subscription status shows overwhelming response from investors, with 59.57 times subscription. QIBs, NIIs, and retail investors actively participated. Price band set at ₹243-256 per share. Analysts bullish on long-term prospects, expecting decent listing gains of over 25%. Continue Reading »
V-Mart acquired Limeroad in FY23 to push its omnichannel strategy, but has been cutting costs to reduce Limeroad’s losses of late..Limeroad’s Ebitda loss in FY24 stood at ₹71.6 crore and V-Mart expects the FY25 loss to be 40-50% of that. Continue Reading »